Bioprofiling Response to Mineralocorticoid Receptor Antagonists for the Prevention of Heart Failure

NCT02556450 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

528

Enrollment

OTHER

Sponsor class

Conditions

Heart Failure

Interventions

DRUG: Spironolacton

Sponsor

ACS Biomarker

Collaborators

[object Object]
[object Object]